Astellas Pharma GmbH v Helm AG and another

European Union – Freedom of movement. The main proceedings had been brought by Astellas Pharma GmbH with regard to the Finnish Medicines Agency's decision to authorise the marketing of a generic medicinal product called 'Alkybend', produced by the first respondent company, Helm AG. In the course of those proceedings, the Court of Justice gave a preliminary ruling on arts 28 and 29 of Directive (EC) 2001/83, as amended, and of art 10 of that directive, read in conjunction with art 47 of the Charter of Fundamental Rights of the European Union.

Category: